In summary, our study uncovered Galectin-8 as a novel intracellular binding partner for K-Ras4B, which modifies K-Ras stability, ERK signaling, and migration and proliferation in pancreatic and lung carcinoma cells. Here, KRAS is linked to lung carcinoma.